Merck, Seagen Takeover Talks Heat Up


© Reuters. Merck (MRK), Seagen (SGEN) Takeover Talks Heat Up – WSJ

By Staff

Takeover talks between Merck (NYSE:) and Seagen (NASDAQ:) have accelerated and the two sides are scheduled to meet this week, the Wall Street Journal reported citing people familiar with the matter.

Last week, the Journal originally reported that Merck was in talks to acquire Seagen and others suitors may also be looking.

While the report added that it is unclear if Merck submitted a formal offer, Wall Street analysts have pegged a price of $200+ per share needed to get a deal done.

The two companies already have existing collaborations and Oppenheimer analyst Jay Olson recently noted that Merck and other large biopharma face patent cliffs that could be filled with a deal for Seagen. Olson pointed to Seagen’s expertise in ADCs, which have increasing roles in the future oncology treatment paradigm. This, he said, was exemplified by the overwhelming efficacy of Seagen’s Enhertu at ASCO2022.

Shares of Seagen gained 4% in pre-open trading Friday to $180 per share.

Leave a Comment

Leading the way

Let's build a better world together

Project planning
Design expertise
Great qualifications

Nullam vestibulum finibus sapien, id consequat mauris tempus auctor.


90 Newport St., Natick, MA 01760

83 Taylor Street, Kings Mountain, NC 28086

22 Birch Hill St., Villa Rica, GA 30180

Support requests

Nullam scelerisque leo felis, quis congue mauris tristique in. Suspendisse pulvinar, felis eu facilisis mattis, turpis odio luctus nisi, et ultrices velit enim quis lacus.

Request a quote

[Insert your contact form here]


Vivamus vehicula dictum elit at bibendum. Etiam finibus eros ut urna auctor ullamcorper. Sed at erat eget nisl rutrum ultrices sed eu ex.


Sign up to receive the latest news and trends from our company.

More questions? Get in touch